Categorie
-
Adhesives
6
Amines
115
Amino Acids
207
Analytical Reagents
750
Antibiotics
270
Bioactive Small Molecules
798
Aroma Chemicals
242
Biochemicals
1142
Boronic Acids
4
Buffers
104
Building Blocks
2162
Carbohydrates
191
Catalysts
117
Chiral Compounds
78
Coccus nucifera oil
0
Detergents
62
Diagnostic Raw Materials
271
Flavours and Fragrance Materials
234
Fluorinated Products
67
Furans
7
Gases in Solution
51
Grignard Reagents
31
HPLC Reagents
8
Imidazoles
18
Indoles
48
Inorganic Chemicals
357
Ion-Pair Reagents
23
Ligands
81
Organics
1628
Oxazoles
3
Peptide Reagents
99
Phenols
55
Picolines
0
Piperazines
13
Pyrazines
3
Pyridines
65
Pyrimidines
36
Quaternary Ammonium salts
45
Reagents
114
Research Organics & Inorganics
885
Salts
308
Sealing Compounds
1
Sherclin
1
Solvents
132
Stains & Indicators
322
Sugars
66
Tailor-made solutions
1
Testing Standards
4
Uncategorised
22
Water Analysis
13
Natamycin (Pimaricin)
(10237077 | 7681-93-8)
CAS: | 7681-93-8 |
---|---|
Formula molecolare: | C33H47NO13 |
Peso molecolare: | 665.73 |
Disponibilità: | In stock |
---|---|
Downloads: | | |
10237077-1g | 1g | £77.70 | |
Ordine all'ingrosso |
10237077-1g | 1g | €108.80 | |
Ordine all'ingrosso |
10237077-1g | 1g | $116.60 | |
Ordine all'ingrosso |
Scheda di sicurezza
Certificato di analisi
Dettagli del prodotto
Product Code | 10237077 | ||||
Product Name | Natamycin (Pimaricin) | ||||
Categories | Antibiotics Bioactive Small Molecules | ||||
CAS | 7681-93-8 | ||||
Molecular Formula | C33H47NO13 | ||||
Molecular Weight | 665.73 | ||||
Storage Details | 2 to 8 °C | ||||
Harmonised Tariff Code | 29419000 |
Specifiche del prodotto
Grade | USP | ||||
pH | 5.0 - 7.5 | ||||
Water Content | 6.0 - 9.0% | ||||
Residue on Ignition | ≤ 0.5% | ||||
Appearance | White to off-white powder | ||||
Lead (Pb) | ≤ 1mg/kg | ||||
Arsenic (As) | ≤ 1mg/kg | ||||
Assay (dried basis) | ≥ 95.0% | ||||
Total Aerobic Microbial Count | ≤ 100cfu/g |
Informazioni sulla sicurezza
Pictograms |
|
||||
Signal word | none | ||||
Hazard statements |
|
||||
Precautionary statements |
|